Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Borrmann

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|June 20, 2002
On blood examinations in East African malaria diseasesSteffen Borrmann
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2019
Controlled Human Malaria Infection (CHMI) Studies: Over 100 Years of Experience with Parasite InjectionsKai Matuschewski, Steffen Borrmann
Current Opinion in Immunology|July 2, 2011
Protective immunity against malaria by 'natural immunization': a question of dose, parasite diversity, or both?Steffen Borrmann, Kai Matuschewski
Trends in Molecular Medicine|July 9, 2011
Targeting Plasmodium liver stages: better late than neverSteffen Borrmann, Kai Matuschewski
Trends in Parasitology|September 25, 2021
Drug-induced hypersensitivity to artemisinin-based therapies for malariaTamara Nordmann, Steffen Borrmann, Michael Ramharter
Parasitology Research|August 26, 2003
Fosmidomycin for the treatment of malariaJochen Wiesner, Steffen Borrmann, Hassan Jomaa
Antimicrobial Agents and Chemotherapy|March 30, 2011
Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistanceJohannes Friesen, Steffen Borrmann, Kai Matuschewski
Plos One|April 22, 2014
Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysisJohannes Pfeil, Steffen Borrmann, Yeşim Tozan
Trends in Parasitology|January 25, 2025
Genetically attenuated parasites show promise as a next-generation malaria vaccineJulius C R Hafalla, Steffen Borrmann, Kai Matuschewski
Human Vaccines|January 27, 2011
Arrested Plasmodium liver stages as experimental anti-malaria vaccinesKai Matuschewski, Julius Clemence Hafalla, Steffen Borrmann, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Journal of Molecular Medicine (Berlin, Germany)|June 20, 2002
On blood examinations in East African malaria diseasesSteffen Borrmann
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2019
Controlled Human Malaria Infection (CHMI) Studies: Over 100 Years of Experience with Parasite InjectionsKai Matuschewski, Steffen Borrmann
Current Opinion in Immunology|July 2, 2011
Protective immunity against malaria by 'natural immunization': a question of dose, parasite diversity, or both?Steffen Borrmann, Kai Matuschewski
Trends in Molecular Medicine|July 9, 2011
Targeting Plasmodium liver stages: better late than neverSteffen Borrmann, Kai Matuschewski
Trends in Parasitology|September 25, 2021
Drug-induced hypersensitivity to artemisinin-based therapies for malariaTamara Nordmann, Steffen Borrmann, Michael Ramharter
Parasitology Research|August 26, 2003
Fosmidomycin for the treatment of malariaJochen Wiesner, Steffen Borrmann, Hassan Jomaa
Antimicrobial Agents and Chemotherapy|March 30, 2011
Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistanceJohannes Friesen, Steffen Borrmann, Kai Matuschewski
Plos One|April 22, 2014
Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysisJohannes Pfeil, Steffen Borrmann, Yeşim Tozan
Trends in Parasitology|January 25, 2025
Genetically attenuated parasites show promise as a next-generation malaria vaccineJulius C R Hafalla, Steffen Borrmann, Kai Matuschewski
Human Vaccines|January 27, 2011
Arrested Plasmodium liver stages as experimental anti-malaria vaccinesKai Matuschewski, Julius Clemence Hafalla, Steffen Borrmann, et al.
Pageof 12